factual
Vaccine Gross and Operating Margins
Moderna's COVID vaccine has cost of sales near 20% and an operating margin near 50%, placing it within normal vaccine economics while above traditional pharma margins.
factualpending
Speaker
Matthew HarrisonEvidence Quote
“Moderna has given guidance that cost of sales is about 20%... operating margin for the vaccine, which they've said is about 50%.”
Created: 11/15/2026, 7:57:10 PM
Your notes
Loading notes...